RS20080388A - Cancer treatments - Google Patents

Cancer treatments

Info

Publication number
RS20080388A
RS20080388A RSP-2008/0388A RSP20080388A RS20080388A RS 20080388 A RS20080388 A RS 20080388A RS P20080388 A RSP20080388 A RS P20080388A RS 20080388 A RS20080388 A RS 20080388A
Authority
RS
Serbia
Prior art keywords
cancer treatments
oxaliplatin
liposome
relates
encapsulated
Prior art date
Application number
RSP-2008/0388A
Other languages
English (en)
Inventor
Parthenios Boulikas
Original Assignee
Parthenios Boulikas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parthenios Boulikas filed Critical Parthenios Boulikas
Publication of RS20080388A publication Critical patent/RS20080388A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Ovaj pronalazak se odnosi na lipozome koji obuhvataju inkapsulirani oksaliplatin i postupke za proizvodnju inkapsuliranog oksaliplatina. Pronalazak se, isto tako, odnosi na lipozome koji obuhvataju oksaliplatin i druge antikancerske lekove. Lipozomi pronalaska mogu se koristiti u tretmanima kancera.
RSP-2008/0388A 2006-03-03 2007-03-05 Cancer treatments RS20080388A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GR20060100144A GR20060100144A (el) 2006-03-03 2006-03-03 Θεραπεια του καρκινου με χρηση οξαλιπλατινης εγκλεισμενης μεσα σε λιποσωματα και απο κοινου εγκλεισμος στο λιποσωμιακο μοριο περισσοτερων απο ενος φαρμακευτικου παρασκευασματος h gene
PCT/GR2007/000015 WO2007099377A2 (en) 2006-03-03 2007-03-05 Cancer treatments

Publications (1)

Publication Number Publication Date
RS20080388A true RS20080388A (en) 2009-07-15

Family

ID=38325437

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2008/0388A RS20080388A (en) 2006-03-03 2007-03-05 Cancer treatments

Country Status (17)

Country Link
US (1) US20090053302A1 (sr)
EP (1) EP2001441A2 (sr)
JP (1) JP2009528340A (sr)
KR (1) KR20090023548A (sr)
CN (1) CN101522172A (sr)
AU (1) AU2007220263A1 (sr)
BR (1) BRPI0707059A2 (sr)
CA (1) CA2644566A1 (sr)
EA (1) EA200801912A1 (sr)
GR (1) GR20060100144A (sr)
MA (1) MA30314B1 (sr)
MX (1) MX2008011263A (sr)
NO (1) NO20083927L (sr)
RS (1) RS20080388A (sr)
TN (1) TNSN08345A1 (sr)
WO (1) WO2007099377A2 (sr)
ZA (1) ZA200807934B (sr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9186322B2 (en) 2002-08-02 2015-11-17 Insmed Incorporated Platinum aggregates and process for producing the same
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
KR20080094473A (ko) * 2007-04-20 2008-10-23 한국화학연구원 음이온성 지질나노입자 및 이의 제조방법
CN104689336A (zh) * 2008-01-28 2015-06-10 那野伽利阿株式会社 医药组合物或组合剂
TWI468188B (zh) * 2008-01-30 2015-01-11 Univ Tokushima Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
WO2009111648A1 (en) * 2008-03-05 2009-09-11 Vicus Therapeutics, Llc Compositions and methods for mucositis and oncology therapies
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
US20120135064A1 (en) * 2009-05-27 2012-05-31 Northeastern University Conjugated nanodelivery vehicles
JP5759464B2 (ja) * 2009-09-21 2015-08-05 ジェイダブリュー ファーマシューティカル コーポレイション オキサリプラチンのナノ粒子及びその製造方法
JP5817053B2 (ja) * 2010-04-02 2015-11-18 国立大学法人 千葉大学 腫瘍特異性を有するリポソーム
CN102133176B (zh) * 2011-03-22 2012-09-05 济南宏瑞创博医药科技开发有限公司 一种奥沙利铂胶束制剂及其制备方法及应用
JP5378469B2 (ja) * 2011-08-11 2013-12-25 学校法人 日本歯科大学 医療用薬剤
ES2733061T3 (es) * 2012-08-10 2019-11-27 Taiho Pharmaceutical Co Ltd Dispersión acuosa de liposomas encapsulantes de oxaliplatino estable y método para estabilización de la misma
AU2012387679A1 (en) * 2012-08-13 2014-10-23 Regulon, Inc. Methods for treatment of cancer using Lipoplatin
MA37931A1 (fr) * 2012-08-13 2016-07-29 Teni Boulikas Procédés améliorés permettant de traiter un cancer avec une toxicité rénale réduite
JP2015530387A (ja) 2012-09-04 2015-10-15 エライゾン ファーマシューティカルズ， エルエルシー 脂質複合体化シスプラチンによる肺癌の再発防止
EA023757B1 (ru) * 2012-12-24 2016-07-29 Общество С Ограниченной Ответственностью "Технология Лекарств" Способ получения липосомальной формы оксалиплатина
US20140271820A1 (en) * 2013-03-13 2014-09-18 Mallinckrodt Llc Liposome oxaliplatin compositions for cancer therapy
EP2979700B1 (en) * 2013-03-27 2018-09-26 Taiho Pharmaceutical Co., Ltd. Antitumor agent including low dose irinotecan hydrochloride hydrate
CN103622912B (zh) * 2013-12-05 2016-02-24 常州金远药业制造有限公司 盐酸多柔比星-多西他赛或紫杉醇脂质体制剂及其制备方法
JP2018505224A (ja) * 2015-02-13 2018-02-22 オーピーナノ シーオー エルティーディーＯＰ Ｎａｎｏ Ｃｏ．，Ｌｔｄ． ナノ粒子を含む組成物並びに腫瘍を治療する方法
CA2977397A1 (en) 2015-03-03 2016-09-09 Cureport, Inc. Dual loaded liposomal pharmaceutical formulations
CN107530283A (zh) 2015-03-03 2018-01-02 奎尔波特股份有限公司 组合脂质体药物制剂
KR101687735B1 (ko) * 2015-09-18 2016-12-19 서울대학교 산학협력단 신규의 동결건조보조제 및 새로운 인지질 용해용 혼합용매를 이용한 리포좀 동결분체의 제조방법
WO2017192502A1 (en) * 2016-05-03 2017-11-09 The American University In Cairo Liposomal delivery systems for oxaliplatin and in dual drug delivery in combination with chemo-sensitizing and chemo-therapeutic agents
WO2017192863A1 (en) * 2016-05-04 2017-11-09 L.E.A.F. Holdings Group Llc Targeted liposomal gemcitabine compositions and methods thereof
CN106074379B (zh) * 2016-07-11 2019-01-25 中国科学院上海药物研究所 聚乙二醇化奥沙利铂前药及其制备方法和用途
CN112656764B (zh) * 2020-12-28 2022-09-02 吉林大学 一种紫杉醇铂类共载靶向长循环脂质体及应用
CN114814023A (zh) * 2022-04-24 2022-07-29 江苏省中医院 脂质分子在作为胃癌化疗药耐药的预测性标志物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060080A (en) * 1990-07-16 2000-05-09 Daiichi Pharmaceutical Co., Ltd. Liposomal products
CA2046997C (en) * 1990-07-16 2000-12-12 Hiroshi Kikuchi Liposomal products
US6511676B1 (en) * 1999-11-05 2003-01-28 Teni Boulikas Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
JP2003535832A (ja) * 2000-06-09 2003-12-02 ブリカス，テニ ポリヌクレオチドおよび薬物の標的化リポソームへのカプセル化
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
US20040022842A1 (en) * 2002-06-03 2004-02-05 Mebiopharm Co., Ltd. Liposome preparations containing oxaliplatin
JP3415131B1 (ja) * 2002-06-03 2003-06-09 メビオファーム株式会社 リポソーム製剤
AU2003302314A1 (en) * 2002-08-02 2004-07-09 Transave, Inc. Platinum aggregates and process for producing the same
WO2004098524A2 (en) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
WO2005000266A2 (en) * 2003-05-22 2005-01-06 Neopharm, Inc. Liposomal formulations comprising a combination of two or more active agents

Also Published As

Publication number Publication date
US20090053302A1 (en) 2009-02-26
ZA200807934B (en) 2009-11-25
TNSN08345A1 (en) 2009-12-29
JP2009528340A (ja) 2009-08-06
MA30314B1 (fr) 2009-04-01
AU2007220263A1 (en) 2007-09-07
KR20090023548A (ko) 2009-03-05
CN101522172A (zh) 2009-09-02
WO2007099377A2 (en) 2007-09-07
WO2007099377A3 (en) 2008-04-17
CA2644566A1 (en) 2007-09-07
EP2001441A2 (en) 2008-12-17
GR20060100144A (el) 2007-10-17
EA200801912A1 (ru) 2009-02-27
BRPI0707059A2 (pt) 2011-04-19
MX2008011263A (es) 2008-12-12
NO20083927L (no) 2008-09-15

Similar Documents

Publication Publication Date Title
TNSN08345A1 (en) Cancer treatments
MX2007010996A (es) Nuevas composiciones de liposomas.
MY146112A (en) Long-term feed - cancer patient
HK1146469A1 (en) Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation
WO2008137867A3 (en) Compositions comprising mir34 therapeutic agents for treating cancer
WO2008015383A8 (en) Bmp-9 and bmp-10 and their use in breast and prostate cancer therapies
MX2013006140A (es) Uso de ligandos sigma en dolor por cancer de huesos.
TN2011000292A1 (en) Amino pyrazole compound
WO2009129387A3 (en) Cationic lipids and uses thereof
MX349321B (es) Terapia combinada.
WO2009140675A3 (en) Combination therapy with pm00104 and another antitumor agent
WO2007105015A3 (en) DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
WO2009095261A3 (en) Vaccine compositions
WO2008063808A3 (en) Encapsulated peptide amphiphile nanostructures
WO2008030818A3 (en) Novel liposome compositions
HK1100484A1 (en) Application of n-butylidenephthalide in preparing cancer treatment medication
WO2008060945A3 (en) Diagnosis and treatment of breast cancer
SI2147122T1 (sl) Encimatska terapija proti raku
EP1635764A4 (en) CONJUGATE FOR THE SPECIFIC TARGETING OF ANTICANCER AGENTS ON CANCER CELLS AND PRODUCTION OF THE CONJUGATE
CA139930S (en) Chocolate confectionery
MXPA05008902A (es) Soluciones de drogas en mentol.
TW200640858A (en) Substituted pyrroles, compositions containing them, method of manufacture and use
WO2010121226A3 (en) Anticancer agents
WO2008092103A3 (en) Combination cancer treatments comprising elsamitrucin and other agents